JavaScript is off. Please enable to view full site.

Abbott developing test for monkeypox

Abbott developing test for monkeypox

Friday, May 27, 2022, 09:07 GMT+7
Abbott developing test for monkeypox
Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. Photo: Reuters

Abbott Laboratories said on Thursday it is actively developing a test for monkeypox, as the disease spreads in various countries.

The company will provide the test kits to partners of its Pandemic Defense Coalition, a network of scientific and public health partnerships aimed at identifying future pandemic threats, an Abbott spokesperson told Reuters.

"As the situation evolves, we will take steps to address additional testing needs," the spokesperson said.

Abbott's announcement comes on a day when the Centers for Diseases Control and Prevention (CDC) confirmed it has identified nine monkeypox cases in seven U.S. states.

Globally, more than 200 confirmed or suspected infections have been recorded in around 20 countries where monkeypox is not endemic. Most of these cases have been found in Europe.

Abbott is the second company to announce its development of monkeypox tests following Roche's (ROG.S) announcement on Wednesday. 



Read more




‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Latest news